Beyond these two genes, TNF Receptor Superfamily Member 18 (TNFRSF18) and Matrix Metallopeptidase 19 (MMP19), also selected by both methods, have been associated with a poor prognosis in glioma [38,39]. This evidence concerns the gene MMP19 and central nervous system cancer.